FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

16048911000001107: Dihydrocodeine 30mg tablets (Bristol Laboratories Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 02-Nov 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
56621601000001112 Dihydrocodeine 30mg tablets (Bristol Laboratories Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
56621701000001119 Dihydrocodeine 30mg tablets (Bristol Laboratories Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Dihydrocodeine 30mg tablets (Bristol Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 5 (CD Inv) true Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Bristol Laboratories Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Bristol Laboratories Ltd) Is a Dihydrocodeine 30mg tablets true Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Bristol Laboratories Ltd) Is a Dihydrocodeine 30mg tablets false Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Bristol Laboratories Ltd) Is a Product containing precisely dihydrocodeine 30 milligram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Bristol Laboratories Ltd) Has active ingredient Dihydrocodeine false Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Bristol Laboratories Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Bristol Laboratories Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Bristol Laboratories Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Bristol Laboratories Ltd) Has specific active ingredient Dihydrocodeine tartrate true Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Bristol Laboratories Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Bristol Laboratories Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Bristol Laboratories Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Dihydrocodeine 30mg tablets (Bristol Laboratories Ltd) 28 tablet 2 x 14 tablets Has AMP True Dihydrocodeine 30mg tablets (Bristol Laboratories Ltd) Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Bristol Laboratories Ltd) 30 tablet 3 x 10 tablets Has AMP True Dihydrocodeine 30mg tablets (Bristol Laboratories Ltd) Inferred relationship Existential restriction modifier
Dihydrocodeine 30mg tablets (Bristol Laboratories Ltd) 100 tablet 10 x 10 tablets Has AMP True Dihydrocodeine 30mg tablets (Bristol Laboratories Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start